替宁酸结构式
|
常用名 | 替宁酸 | 英文名 | Tienilic acid |
|---|---|---|---|---|
| CAS号 | 40180-04-9 | 分子量 | 331.17 | |
| 密度 | 1.5±0.1 g/cm3 | 沸点 | 534.6±50.0 °C at 760 mmHg | |
| 分子式 | C13H8Cl2O4S | 熔点 | 148-149ºC | |
| MSDS | 中文版 美版 | 闪点 | 277.1±30.1 °C |
替宁酸用途铁粉酸是一种尿酸利尿剂。噻吩酸具有一定的肝毒性[1][3]。 |
| 中文名 | 替宁酸 |
|---|---|
| 英文名 | tienilic acid |
| 中文别名 | 2,3-二氯-4-(2-噻吩甲酰基)苯氧基乙酸 | 噻吩利尿酸 | 2-(2,3-二氯-4-(噻吩-2-羰基)苯氧基)乙酸 |
| 英文别名 | 更多 |
| 描述 | 铁粉酸是一种尿酸利尿剂。噻吩酸具有一定的肝毒性[1][3]。 |
|---|---|
| 相关类别 | |
| 体内研究 | Tienilic acid(大鼠和小鼠为100 mg/lg,猪和狗为5 mg/kg;PO和IV;单次剂量)仅存在于血浆中,通过胆汁和尿液禁食消除,在不同物种中表现出微小差异【2】。替尼酸(0-480 mg/kg;PO;持续28天)可降低血压、血清、尿酸血红蛋白,并增加S-GPT;诱导小群肝细胞的单细胞坏死[3]。动物模型:大鼠、小鼠、猪和狗【2】剂量:大鼠和小鼠100 mg/lg,猪和狗5 mg/kg给药:PO和IV;单次给药结果:仅在血液水平与血浆蛋白有重要结合的血浆中发现;药理作用数小时;在给药后的前48小时内,通过胆道,尤其是尿路禁食,几乎完全消除;在不同物种中测量的参数只有很小的差异。动物模型:雌性和雄性Sprague-Dawley大鼠【3】剂量:0、30、120和480 mg/kg给药:PO;28天结果:30 mg/kg时血压和血尿酸降低;在120和480 mg/kg时,血红蛋白略有下降,S-GPT升高;显著增加雄性大鼠的肝脏重量和血清镁浓度,而雌性大鼠的肝脏重量仅略有增加;此外,诱导小群肝细胞单细胞坏死。 |
| 参考文献 |
[3]. Oker-Blom C, et al. Toxicological studies on tienilic acid in rats. Toxicol Lett. 1980;6(2):93-99. |
| 密度 | 1.5±0.1 g/cm3 |
|---|---|
| 沸点 | 534.6±50.0 °C at 760 mmHg |
| 熔点 | 148-149ºC |
| 分子式 | C13H8Cl2O4S |
| 分子量 | 331.17 |
| 闪点 | 277.1±30.1 °C |
| 精确质量 | 329.952026 |
| PSA | 91.84000 |
| LogP | 3.07 |
| 蒸汽压 | 0.0±1.5 mmHg at 25°C |
| 折射率 | 1.632 |
| 储存条件 | -20°C |
| 危害码 (欧洲) | Xi |
|---|---|
| 危险品运输编码 | NONH for all modes of transport |
| RTECS号 | AG9300000 |
| 海关编码 | 2934999090 |
| 替宁酸上游产品 0 | |
|---|---|
| 替宁酸下游产品 1 | |
| 海关编码 | 2934999090 |
|---|---|
| 中文概述 | 2934999090. 其他杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Physicochemical and drug metabolism characterization of a series of 4-aminoquinoline-3-hydroxypyridin-4-one hybrid molecules with antimalarial activity.
Expert Opin. Drug Metab. Toxicol. 10(10) , 1313-24, (2014) Drug resistance by Plasmodium falciparum remains a challenge in malaria chemotherapy. This paper will focus on physicochemical and drug metabolism characterization of a series of 4-aminoquinoline-3-hy... |
|
|
Coupling Laser Diode Thermal Desorption with Acoustic Sample Deposition to Improve Throughput of Mass Spectrometry-Based Screening.
J. Biomol. Screen. 21 , 165-75, (2016) The move toward label-free screening in drug discovery has increased the demand for mass spectrometry (MS)-based analysis. Here we investigated the approach of coupling acoustic sample deposition (ASD... |
|
|
Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.
Chem. Res. Toxicol. 21(9) , 1814-22, (2008) In vitro covalent binding assessments of drugs have been useful in providing retrospective insights into the association between drug metabolism and a resulting toxicological response. On the basis of... |
| Tienilic acid |
| (2,3-Dichloro-4-(2-thienylcarbonyl)phenoxy)acetic acid |
| Tienilico acido |
| (2,3-Dichloro-4-(2-thiophenecarbonyl)phenoxy)acetic acid |
| Acidum tienilicum |
| TienilicAcid |
| Selacryn |
| acetic acid, [2,3-dichloro-4-(2-thienylcarbonyl)phenoxy]- |
| Diflurex |
| Ticrynafen Tienylic acid [2,3-Dichloro-4-(2-thienylcarbonyl)phenoxy]-acetic acid |
| [2,3-dichloro-4-(2-thenoyl)phenoxy]acetic acid |
| Acido tienilico |
| Acide tienilique |
| 2,3-dichloro-4-(thien-2-ylcarbonyl)-phenoxyacetic acid |
| [2,3-dichloro-4-(thiophene-2-carbonyl)-phenoxy]-acetic acid |
| [2,3-Dichloro-4-(2-thienylcarbonyl)phenoxy]acetic acid |
| Acetic acid, 2-[2,3-dichloro-4-(2-thienylcarbonyl)phenoxy]- |
| Ticrex |
| {[2,3-dichloro-4-(2-thienylcarbonyl)phenyl]oxy}acetic acid |
| Ticrynafen |
| 2-[2,3-dichloro-4-(thiophene-2-carbonyl)phenoxy]acetic acid |
| Thienylic acid |
| [2,3-dichloro-4-(thiophen-2-ylcarbonyl)phenoxy]acetic acid |